NMGAX
Price
$14.97
Change
+$0.09 (+0.60%)
Updated
Apr 17 closing price
Net Assets
1.62B
PMAQX
Price
$42.67
Change
+$0.16 (+0.38%)
Updated
Apr 17 closing price
Net Assets
28.23B
Ad is loading...

NMGAX vs PMAQX

Header iconNMGAX vs PMAQX Comparison
Open Charts NMGAX vs PMAQXBanner chart's image
Neuberger Berman Mid Cap Growth A
Price$14.97
Change+$0.09 (+0.60%)
VolumeN/A
Net Assets1.62B
Principal MidCap R6
Price$42.67
Change+$0.16 (+0.38%)
VolumeN/A
Net Assets28.23B
NMGAX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NMGAX vs. PMAQX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMGAX is a Buy and PMAQX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 28.2B vs. NMGAX (1.62B). PMAQX pays higher dividends than NMGAX: PMAQX (0.20) vs NMGAX (0.00). NMGAX was incepted earlier than PMAQX: NMGAX (16 years) vs PMAQX (8 years). NMGAX (1.06) is less costly to investors than PMAQX (0.60). NMGAX is a more actively managed with annual turnover of: 97.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than NMGAX: PMAQX (0) vs NMGAX (1000). PMAQX annual gain was more profitable for investors over the last year : 7.05 vs. NMGAX (-7.58). PMAQX return over 5 years is better than : 63.57 vs. NMGAX (2.48).
NMGAXPMAQXNMGAX / PMAQX
Total Expense Ratio1.060.60177%
Annual Report Gross Expense Ratio1.060.60177%
Fund Existence16 years8 years-
Gain YTD-11.848-4.750249%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.62B28.2B6%
Annual Yield % from dividends0.000.20-
Returns for 1 year-7.587.05-107%
Returns for 3 years-6.8819.48-35%
Returns for 5 years2.4863.574%
Returns for 10 years3.28N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDYA17.080.90
+5.56%
IDEAYA Biosciences
PRLD0.810.04
+5.19%
Prelude Therapeutics
FCFS121.441.38
+1.15%
FirstCash Holdings
EGHT1.58N/A
N/A
8x8
INFY16.14-0.44
-2.65%
Infosys Limited